PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 34840584-10 2021 Cyclophosphamide upregulated the expressions of NF-kappaB p65, TLR4, and MyD88, suggesting that the NF-kappaB signaling pathway was activated by cyclophosphamide. Cyclophosphamide 0-16 nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus 100-109 16595331-0 2006 Effect of millimeter waves on cyclophosphamide induced NF-kappaB. Cyclophosphamide 30-46 nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus 55-64 16595331-2 2006 The effect of millimeter waves (MMWs) on NF-kappaB activation induced by cyclophosphamide (CPA) was studied in the spleen of mice. Cyclophosphamide 73-89 nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus 41-50 16595331-2 2006 The effect of millimeter waves (MMWs) on NF-kappaB activation induced by cyclophosphamide (CPA) was studied in the spleen of mice. Cyclophosphamide 91-94 nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus 41-50 16595331-3 2006 CPA, an anticancer drug, caused a marked increase (58.9-fold) in NF-kappaB DNA-binding activity as compared to the control group. Cyclophosphamide 0-3 nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus 65-74 34482064-0 2021 Betulinic acid attenuates cyclophosphamide-induced intestinal mucosa injury by inhibiting the NF-kappaB/MAPK signalling pathways and activating the Nrf2 signalling pathway. Cyclophosphamide 26-42 nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus 94-103 34865774-0 2021 Sulfated modification enhances the immunomodulatory effect of Cyclocarya paliurus polysaccharide on cyclophosphamide-induced immunosuppressed mice through MyD88-dependent MAPK/NF-kappaB and PI3K-Akt signaling pathways. Cyclophosphamide 100-116 nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus 176-185 34840584-10 2021 Cyclophosphamide upregulated the expressions of NF-kappaB p65, TLR4, and MyD88, suggesting that the NF-kappaB signaling pathway was activated by cyclophosphamide. Cyclophosphamide 145-161 nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus 100-109 35504331-0 2022 Trimetazidine attenuates cyclophosphamide-induced cystitis by inhibiting TLR4-mediated NFkappaB signaling in mice. Cyclophosphamide 25-41 nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus 87-95 34689333-0 2022 Laminaria japonica fucoidan ameliorates cyclophosphamide-induced liver and kidney injury possibly by regulating Nrf2/HO-1 and TLR4/NF-kappaB signaling pathways. Cyclophosphamide 40-56 nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus 131-140 33238601-0 2020 Raspberry Ketones Attenuate Cyclophosphamide-Induced Pulmonary Toxicity in Mice through Inhibition of Oxidative Stress and NF-KappaB Pathway. Cyclophosphamide 28-44 nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus 123-132 33716060-0 2021 Ligustrazine alleviates cyclophosphamide-induced hepatotoxicity via the inhibition of Txnip/Trx/NF-kappaB pathway. Cyclophosphamide 24-40 nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus 96-105 35576032-0 2022 Ameliorative effect of flavocoxid on cyclophosphamide-induced cardio and neurotoxicity via targeting the GM-CSF/NF-kappaB signaling pathway. Cyclophosphamide 37-53 nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus 112-121 28575809-0 2017 Lutein mitigates cyclophosphamide induced lung and liver injury via NF-kappaB/MAPK dependent mechanism. Cyclophosphamide 17-33 nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus 68-77 31089650-0 2019 Protective effects of polysaccharides from Cordyceps gunnii mycelia against cyclophosphamide-induced immunosuppression to TLR4/TRAF6/NF-kappaB signalling in BALB/c mice. Cyclophosphamide 76-92 nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus 133-142 29044685-8 2018 CPA markedly increased phosphorylated NF-kappaB p65 levels in the bladder, an effect that was prevented by pyrrolidine dithiocarbamate (PDTC), an NF-kappaB inhibitor. Cyclophosphamide 0-3 nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus 38-47 29044685-8 2018 CPA markedly increased phosphorylated NF-kappaB p65 levels in the bladder, an effect that was prevented by pyrrolidine dithiocarbamate (PDTC), an NF-kappaB inhibitor. Cyclophosphamide 0-3 nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus 146-155 29044685-9 2018 PDTC and curcumin, which inhibits NF-kappaB signals, abolished CPA-induced nociceptive behaviour, referred hyperalgesia and, in part, increases in bladder weight. Cyclophosphamide 63-66 nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus 34-43 29044685-11 2018 The CPA-induced activation of NF-kappaB signals appeared to cause CSE overexpression in the bladder, contributing to bladder pain and in part swelling, possibly through H2 S/Cav 3.2 signaling. Cyclophosphamide 4-7 nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus 30-39 31136760-5 2019 CPA increased hepatic infiltration of neutrophils, liver myeloperoxidase (MPO) activity, serum interleukin-6 (IL-6) content, hepatic IL-6 mRNA expression, toll-like receptor-4 (TLR4) expression and nuclear factor kappaB (NFkappaB) activation in mice. Cyclophosphamide 0-3 nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus 221-229 31136760-9 2019 In summary, these results indicate that TLR4-NFkappaB-mediated inflammatory injury initiated by DAMPs was critically involved in CPA-induced hepatotoxicity. Cyclophosphamide 129-132 nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus 45-53 18395765-2 2008 Here, a teratogen such as cyclophosphamide (CP) was used to test whether teratogenic insult alters the classical NF-kappaB activation pathway, and how these alterations correlate with the ability of mouse embryos to resist the teratogen-induced process of maldevelopment. Cyclophosphamide 26-42 nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus 113-122 17660247-0 2007 p53 regulates cyclophosphamide teratogenesis by controlling caspases 3, 8, 9 activation and NF-kappaB DNA binding. Cyclophosphamide 14-30 nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus 92-101